GC
TECX

GMT Capital’s Tectonic Therapeutic TECX Stock Holding History

GMT Capital’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-201,001
Closed -$2.29M – 110
2023
Q2 		$2.29M Sell
201,001
-162,154
-45% -$1.83M 0.09% 60
2023
Q1 		$4.36M Buy
363,155
+87,333
+32% +$1.22M 0.17% 54
2022
Q4 		$2.36M Sell
275,822
-15,386
-5% -$135K 0.11% 54
2022
Q3 		$2.25M Hold
291,208
– – 0.14% 67
2022
Q2 		$3.21M Buy
291,208
+74,965
+35% +$884K 0.2% 54
2022
Q1 		$3.42M Hold
216,243
– – 0.22% 45
2021
Q4 		$9.99M Buy
216,243
+38,475
+22% +$2.21M 0.77% 26
2021
Q3 		$11.9M Hold
177,768
– – 1.05% 23
2021
Q2 		$19M Buy
177,768
+47,562
+37% +$5.64M 1.42% 18
2021
Q1 		$19.8M Buy
+130,206
New +$21.2M 1.46% 17

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

GMT Capital's TECX Position: Q3 2023 in Review

GMT Capital sold out of Tectonic Therapeutic (TECX) in Q3 2023, closing a stake of 201,001 shares — an estimated $2.29M sold.

GMT Capital first reported a position in TECX in Q1 2021 and held it in 10 quarters. The position peaked at $19.8M in Q1 2021. 47 funds tracked by Wall St. Rank hold TECX as of Q3 2023.

  • GMT Capital reported no remaining Tectonic Therapeutic position as of Q3 2023 after selling out during the quarter.
  • GMT Capital sold 201,001 Tectonic Therapeutic shares in Q3 2023, an estimated $2.29M.
  • GMT Capital first reported a position in Tectonic Therapeutic in Q1 2021 and held it in 10 quarters.
  • GMT Capital's Tectonic Therapeutic position peaked at $19.8M in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2023.

Based on GMT Capital's 13F filing for Q3 2023, filed 13 Nov 2023.